| Literature DB >> 31117209 |
Aubrey L Arain1, Richard L Neitzel2.
Abstract
Electronic waste recycling presents workers and communities with a potential for exposures to dangerous chemicals, including metals. This review examines studies that report on blood, hair, and urine biomarkers of communities and workers exposed to metals from e-waste. Our results from the evaluation of 19 publications found that there are consistently elevated levels of lead found in occupationally and non-occupationally exposed populations, in both the formal and the informal e-waste recycling sectors. Various other metals were found to be elevated in different exposure groups assessed using various types of biomarkers, but with less consistency than found in lead. Antimony and cadmium generally showed higher concentrations in exposed groups compared to reference group(s). Mercury and arsenic did not show a trend among exposure groups due to the dietary and environmental considerations. Observed variations in trends amongst exposure groups within studies using multiple biomarkers highlights the need to carefully select appropriate biomarkers. Our study concludes that there is a need for more rigorous research that moves past cross-sectional study designs, involves more thoughtful and methodical selection of biomarkers, and a systematic reporting standard for exposure studies to ensure that results can be compared across studies.Entities:
Keywords: biomarker; e-waste; metals
Mesh:
Substances:
Year: 2019 PMID: 31117209 PMCID: PMC6572375 DOI: 10.3390/ijerph16101802
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Flow diagram illustrating database search and study selection methodology.
Summary of biomarker measurement types for the study set including total values. Gray cells indicate the presence of biomarker or element in each study.
| Publication | Biomarkers | Element | |||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Whole Blood | Serum | Plasma | Urine | Hair | Ag | Al | Sb | As | Ba | Be | Bi | Cd | Cr | Cs | Co | Cu | Fe | I | In | Ga | Hg | Pb | Mg | Mn | Mo | Ni | Pt | Rb | Se | Sn | Sr | Tl | U | V | W | Zn | |
| Amankwaa et al., 2017 [ | |||||||||||||||||||||||||||||||||||||
| Asante et al., 2012 [ | |||||||||||||||||||||||||||||||||||||
| Ceballos et al., 2017 [ | |||||||||||||||||||||||||||||||||||||
| Dartey et al., 2017 [ | |||||||||||||||||||||||||||||||||||||
| Ha et al., 2009 [ | |||||||||||||||||||||||||||||||||||||
| Huang et al., 2014 [ | |||||||||||||||||||||||||||||||||||||
| Julander et al., 2014 [ | |||||||||||||||||||||||||||||||||||||
| Li et al., 2014 [ | |||||||||||||||||||||||||||||||||||||
| Ni et al., 2014 [ | |||||||||||||||||||||||||||||||||||||
| Noguchi et al., 2014 [ | |||||||||||||||||||||||||||||||||||||
| Schecter et al., 2017 [ | |||||||||||||||||||||||||||||||||||||
| Srigboh et al., 2016 [ | |||||||||||||||||||||||||||||||||||||
| Tang et al., 2015 [ | |||||||||||||||||||||||||||||||||||||
| Tokumaru et al., 2017 [ | |||||||||||||||||||||||||||||||||||||
| Wang et al., 2010 [ | |||||||||||||||||||||||||||||||||||||
| Wang et al., 2011 [ | |||||||||||||||||||||||||||||||||||||
| Wittsiepe et al., 2017 [ | |||||||||||||||||||||||||||||||||||||
| Zhang et al., 2018 [ | |||||||||||||||||||||||||||||||||||||
| Zheng et al., 2011 [ | |||||||||||||||||||||||||||||||||||||
|
| 9 | 4 | 2 | 10 | 8 | 2 | 1 | 5 | 6 | 2 | 1 | 4 | 12 | 7 | 2 | 6 | 10 | 7 | 1 | 4 | 3 | 10 | 14 | 2 | 6 | 5 | 6 | 1 | 2 | 5 | 4 | 2 | 4 | 1 | 5 | 2 | 8 |
Summary results of the study set, including exposure groups, demographics, results, main conclusions, and conclusions from sample types other than metal biomarkers.
| Publication | Country | Industry | Exposure Group | Total | Male | Child | Age Mean (SD) | Age Range | Smokers | Elevated Metals | Main Conclusion(s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Amankwaa et al., 2017 [ | Ghana | Informal | Occupational | 81 | NR | NR | NR | NR | NR | B–Pb | Workers who burned e-waste had highest BLLs. No significant difference between exposure groups, indicating environmental exposures are important. Years in e-waste, weekly work hours, residence, and frequency of changing work clothes significantly correlated with BLL. |
| Non-occupational | 33 | NR | NR | NR | NR | NR | B–Pb | ||||
| Control group | 14 | NR | NR | NR | NR | NR | |||||
| Asante et al., 2012 [ | Ghana | Informal | Occupational | 20 | 20 (100) | NR | 27 | 15–42 | 5 (25) | U–Fe, Sb, Pb | Concentrations of Fe, Sb, and Pb in urine of e-waste workers significantly higher than reference levels after interaction by age, indicating that workers are exposed through recycling. Primary species in urine were arsenobetaine and dimethylarsinic acid and both were positively correlated with total arsenic and with each other. Relative concentration of As in urine was high but was low in water, suggesting common exposure source for As compounds, probably fish and shellfish. |
| Reference group—gold mining | 25 | 3 (12) | NR | 45 | 19–81 | 1 (4) | |||||
| Non-occupational | 3 | 2 (67) | NR | 30 | 16–40 | 0 (0) | |||||
| Ceballos et al., 2017 [ | USA | Formal | Occupational | 46 | NR | 0 | NR | NR | NR | B–Pb | Pb and Cd were primary metals of concern, but this may differ in time and place given variability of e-waste recycling stream, where additional metals can be present. |
| Dartey et al., 2017 [ | Ghana | Informal | Occupational—LBRW | 64 | 64 (100) | 0 | 31.8 | 20–49 | 2 (3) | S–Pb; B–Pb; U–Pb, I, Sb; | B-Co, Se, and Hg elevated in whole population. Concentrations of B-Hg highly associated with B-Se and As, indicating fish consumption as a common source. Higher concentrations of Cd and Sn may be related to soldering during repair work, while higher S-Mn, Cr, and Ni may point to welding. U-Cr, Hg, and Sn negatively associated with BMI. |
| Occupational—ERW | 64 | 64 (100) | 0 | 32.6 | 18–50 | 0 | S–Mn, Cr; U–As, I, Sn | ||||
| Non-occupational—Male referent group | 65 | 65 (100) | 0 | 30.2 | 18–50 | 1 (2) | |||||
| Non-occupational—FPT | 26 | 0 | 0 | 34.2 | 20–49 | 0 | B–Cu; S–Cu, Se; U–Co | ||||
| Ha et al., 2009 [ | India | Both | Occupational—Informal | 5 | 5 | 0 | NR | NR | NR | H–Cu, Sb, Bi, Hg, Ag | Elevated levels from recycling sites compared to control sites suggest exposure to those elements found at both sites (Cu, Sb, Bi) may be common to recycling activities, whereas differences between sites (Mo, Pb, Hg, Ag) suggest site-specific exposures that might be caused by differences in methods of recycling used. |
| Occupational—Formal | 6 | 6 | 0 | NR | NR | NR | H–Cu, Sb, Bi, Pb, Mo | ||||
| Control group | 8 | 8 | 0 | NR | NR | NR | |||||
| Huang et al., 2014 [ | China | Informal | Occupational | 138 | 197 (96) 1 | 0 | 23.07 (7.9) 1 | NR | NR | Sb | Sb concentrations highest in e-waste workers, then non-occupationally exposed group, compared to control group. |
| Non-occupational | 67 | 197 (96) 1 | 0 | 23.07 (7.9) 1 | NR | NR | Sb | ||||
| Control group | 80 | 55 (68.8) | 0 | 21.90 (0.8) | NR | NR | |||||
| Julander et al., 2014 [ | Sweden | Formal | Occupational—BL | 53 | 46 (87) | 0 | NR | NR | NR | B–Pb, Cr; U–Pb, Hg; | Few differences found in exposure patterns between different work tasks. Rare metals must be monitored as well as more well-known metals. Correlation between some metals (Sb, V, Hg, In, Pb) in air samples and biomarkers. |
| Non-occupational—BL | 10 | 8 (80) | 0 | NR | NR | NR | |||||
| Occupational—FU | 25 | 18 (72) | 0 | NR | NR | NR | B–Pb, Co; U–Pb, Hg; | ||||
| Non-occupational—FU | 7 | 5 (71) | 0 | NR | NR | NR | |||||
| Li et al., 2014 [ | China | Informal | Non-occupational | 30 | 16 (53) | NR | 41 (11.0) | NR | 0 | B–Cu, Pb, Mg | Non-occupational exposure group had reduced beneficial minerals (Ca, Zn) and increased Pb, Cu, and Mg compared to the control group. Pb levels in the non-occupational exposure group were 50% higher than control group, indicating chronic Pb poisoning. |
| Control group | 28 | 14 (50) | NR | 33 (2.1) | NR | 0 | |||||
| Ni et al., 2014 [ | China | NR | Occupational and Non-occupational | 205 | 197 (96) | 0 | 23.07 (7.9) | NR | NR | H–Hg | Male participants significantly more likely to have higher Hg concentrations in both exposure groups. Living near e-waste activities for a long time and working with e-waste may be important contributors to Hg in hair. |
| Control group | 80 | 55 (68) | 0 | 21.9 (0.8) | NR | NR | |||||
| Noguchi et al., 2013 [ | Vietnam | Informal | Occupational and Non-occupational—Sampling event 1 | 49 | 16 (33) | 0 | NR | NR | NR | B–Pb; U–Pb; H-Pb; | Males had higher levels of Pb in blood, urine, and hair; likely from task differences. Participants from all exposure groups had BLLs above 10 μg/dL and were comparable to other areas known to be contaminated with dangerous levels of Pb. |
| Occupational and Non-occupational—Sampling event 2 | 93 | 30 (32.3) | 23 (24.7) | NR | NR | NR | B–Pb; | ||||
| Control group—Urban—Sampling event 1 | 20 | 9 (45) | 0 | NR | NR | NR | |||||
| Control group—Rural—Sampling event 1 | 71 | 24 (33.8) | 5 (7) | NR | NR | NR | |||||
| Schecter et al., 2017 [ | Vietnam | Informal | Occupational | 40 | 0 | 0 | median 39 | 18–52 | 0 | B–Pb; U–Pb; | B–Pb, Cd and Hg in both exposure groups were elevated compared with NHANES. Higher levels of Hg and MeHg among the control group likely due to differences in diet. Occupational exposure to Pb occurred among recyclers. Exposure to As, Pb, and Hg was environmental. |
| Control group | 20 | 0 | 0 | median 37 | 18–52 | 0 | B–Hg, B–MeHg; | ||||
| Srigboh et al., 2016 [ | Ghana | Informal | Occupational | 58 | 58 | 0 | 25.9 (7.9) | NR | NR | B–Cd, Pb; U–As | Many blood and urinary elements were within reference ranges. B–Cd, Pb, and U–As were elevated compared to background populations elsewhere. Workers who burned e-waste had highest biomarker levels. |
| Non-occupational | 11 | 0 | 0 | 26 (12.8) | NR | NR | |||||
| Tang et al., 2015 [ | China | NR | Occupational—Industrial scale e-waste | NR | NR | NR | NR | NR | NR | H–IHg | High MeHg in control group and industrial-scale e-waste group likely due to heavier fish consumption. Higher T–Hg and I–Hg in small-scale group likely from work exposures. Highest mean concentrations of T–Hg and I–Hg in acid bath workers, followed by workers who burn electronics, dismantlers, and administrators. |
| Non-occupational—small-scale e-waste | NR | NR | NR | NR | NR | NR | |||||
| Non-occupational—Industrial scale e-waste | NR | NR | NR | NR | NR | NR | H–MeHg | ||||
| Control group | NR | NR | NR | NR | NR | NR | H–MeHg | ||||
| Tokumaru et al., 2017 [ | Ghana | Informal | Non-occupational | 56 | 54 (96) | NR | 32 | 6–65 | NR | H–V, Fe, Cu, Mo, Cd, Sn, Sb, Pb | Isotopic ratios indicate that Pb originated from contaminated soils, fish, and foodstuff. Humans living around e-waste site more exposed to certain metals (see column to left), and these elements were included in same cluster during analysis; they could have originated from contaminated soil at e-waste site. |
| Control group | 10 | 7 (70) | NR | 20 | 13–33 | NR | H–Mg, Sr, Ba | ||||
| Wang et al., 2010 [ | China | Informal | Occupational—Females | 100 | 0 | 0 | 47.01 (0.6) 3 | NR | (26) 3 | B–Fe | Both occupational exposure groups had significantly increased B–Fe levels compared to control group, but not compared to non-occupationally exposed group. Drinking was significantly correlated with elevated lg B–Fe. |
| Non-occupational—Females | 54 | 0 | 0 | 51.28 (1.5) 3 | NR | (10) 3 | B–Fe | ||||
| Control—Females | 59 | 0 | 0 | 54.85 (0.6) 3 | NR | NR | |||||
| Occupational—Males | 98 | 98 (100) | 0 | 47.01 (0.6) 3 | NR | (26) 3 | |||||
| Non-occupational—Males | 34 | 34 (100) | 0 | 51.28 (1.520) 3 | NR | (10) 3 | |||||
| Control—Males | 32 | 32 (100) | 0 | 54.85 (0.6) 3 | NR | NR | |||||
| Wang et al., 2011 [ | China | Informal | Occupational and Non-occupational | 48 | 34 (71) | 0 | 37.2 (8.1) | NR | 25 (52) | B–Pb | Length of time spent working with e-waste or living near an e-waste site may contribute to an increase in BLLs. |
| Control | 56 | 31 (55) | 0 | 39.6 (8.2) | NR | 25 (45) | U–Cd | ||||
| Wittsiepe et al., 2017 [ | Ghana | Informal | Occupational | 73 | 61 (84) | NR | 26.1 (9.6) | NR | (22) 2 | B–Pb; U–Ni, Cd, Cr. | BLLs were elevated in both exposure groups, and the occupational exposure group had significantly higher BLLs than the control group. Exposure to Hg, Pb, Cr, and Ni in Ghana is higher than German background levels. |
| Control group | 37 | 29 (78) | NR | 25.2 (7.4) | NR | (10) 2 | |||||
| Zhang et al., 2018 [ | China | NR | Non-occupational—mother/male newborn | 123 | 0 | NR | 26.29 (4.27) 4 | NR | 1 (0.4) 4 | U–Cd | Maternal U–Cd levels in non-occupational exposure groups higher than other populations, both inside and outside of China, indicating that the elevated U–Cd levels were the result of environmental Cd contamination in the e-waste site of Guiyu, China. |
| Non-occupational—mother/female newborn | 113 | 0 | NR | 26.29 (4.27) 4 | NR | 1 (0.4) | U–Cd | ||||
| Control group—mother/male newborn | 111 | 0 | NR | 28.52 (4.33) 4 | NR | 2 (1) 4 | |||||
| Control group—mother/female newborn | 101 | 0 | NR | 28.52 (4.33) 4 | NR | 2 (1) 4 | |||||
| Zheng et al., 2011 [ | China | Informal | Occupational | 40 | NR | 0 | NR | NR | NR | H–Cd, Cu, Pb | Order of concentrations of metals in hair was: Zn > Pb, Cu > Cd > Ni, with highest levels found in the occupational exposure group. Elevated Cd, Pb, and Cu levels among occupational group likely to have originated from e-waste recycling activities. The distribution pattern of heavy metals in hair samples revealed that children are particularly vulnerable to heavy metal pollution caused by e-waste. |
| Non-occupational | 46 | 37 (80) | 22 | NR | NR | NR | H–Cd, Cu, Pb | ||||
| Control group | 39 | 34 (87) | 11 | NR | NR | NR |
NR = Not Reported; H = Hair; B = Blood; S = Serum; U = Urine; LBRW = Lead Acid Battery Recycling Workers; ERW = Electronic Recycling Workers; FPT = Female Petty Traders; BL = Baseline; FU = Follow-Up; BLL = Blood Lead Levels; PBDE = Polybrominated Diphenyl Ether; PCB = Polychlorinated Biphenyls; NHANES = National Health And Nutrition Examination Survey; THg = Total Mercury; MeHg = Methyl Mercury; IHg = Inorganic Mercury; 1 Data available only for occupational and non-occupational exposure groups combined. 2 From larger dataset (Feldt et al. [47] (2014)). 3 Male and female exposure groups pooled. 4 Mothers of male/female newborns pooled.
Categories and results of the modified Newcastle–Ottawa Scale for cross-sectional studies.
| Sample Selection (4 Stars) | Analysis (2 Stars) | Comparability (4 Stars) | Outcome (1 Star) | Total (11 Stars) | ||||
|---|---|---|---|---|---|---|---|---|
| Publication | 1. Representativeness of Sample: a ** Random; b * Non-Random; c Selected Groups; d No Description | 2. Sample Size: a * Justified and Satisfactory; b Not Justified | 3. Non-Respondents: a * Comparability and Response Rate Satisfactory; b Comparability and/or Response Rate Unsatisfactory; c No Description | 4. Exposure Measurement: a ** Validated Method; b * Non-Validated Method but Method Available or Described; c No Description | 5. Comparison Group: a * Described by Authors as Geographically Distinct; b * Same Community; c No Comparison Group | 6. Subjects in Outcome Groups Comparable: a * Study Controls for Most Important Confounder; b * Study Controls for Any Additional Confounder; c Study Did not Control for Any Confounder. d No Comparison Group | 7. Statistical Test: a * Clearly Described and Appropriate; b Not Described, not Appropriate, or Incomplete | |
| Amankwaa et al., 2017 [ | b * | a * | c | a ** | a * b * | a * b * | a * | 9 |
| Asante et al., 2012 [ | d | b | c | a ** | a* | a* | a * | 5 |
| Ceballos et al., 2017 [ | d | b | c | a ** | c | d | b | 2 |
| Dartey et al., 2017 [ | d | b | c | a ** | b * | a * b * | a * | 6 |
| Ha et al., 2009 [ | d | b | c | a ** | a * | c | b | 3 |
| Huang et al., 2014 [ | d | b | c | a ** | a * | a * b* | a * | 6 |
| Julander et al., 2014 [ | d | b | c | a ** | b * | c | a * | 4 |
| Li et al., 2014 [ | a ** | b | c | b * | a * | a * b * | a * | 7 |
| Ni et al., 2014 [ | c | b | c | a ** | a * | a * b * | a * | 6 |
| Noguchi et al., 2013 [ | d | b | c | a ** | a * | a * b * | a * | 6 |
| Schecter et al., 2017 [ | d | b | c | a ** | a * | a * b * | a * | 6 |
| Srigboh et al., 2016 [ | c | b | c | a ** | b * | c | a * | 4 |
| Tang et al., 2015 [ | d | b | c | a ** | a * b * | c | a * | 5 |
| Tokumaru et al., 2017 [ | c | b | c | a ** | a * | c | a * | 4 |
| Wang et al., 2010 [ | a ** | b | c | a ** | a * b * | a * | a * | 8 |
| Wang et al., 2011 [ | b * | b | c | a ** | a * | a * b * | a * | 7 |
| Wittsiepe et al., 2017 [ | a ** | b | c | a ** | a * | a * b * | a * | 6 |
| Zhang et al., 2018 [ | d | b | c | a ** | a * | c | a * | 4 |
| Zheng et al., 2011 [ | d | b | c | a ** | a * b * | a * | a * | 6 |
For an explanation of scale scoring, please see Supplementary Table S1.
Results of data extraction from a study set for Pb biomarkers in blood, serum, plasma, urine, and hair.
| Authors |
| Ref Level | Ref Level | Ref Level | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Blood (μg/dL) | 10 μg/dL 6 | Urine (μg/g) | 0.50 μg/g 7 | Hair (μg/g) | 6.3 μg/g 8 | ||||||||||||||||||||
| Min | Max | Mean | SD | GM | Med | 25th %ile | 75th %ile | 90th %ile | Min | Max | Mean | SD | GM | Med | 25th %ile | 75th %ile | 90th %ile | Min | Max | Mean | SD | GM | Med | ||
| Ha et al., 2009 [ | 5 | 2.38 | 74.5 | 9.07 | |||||||||||||||||||||
| 6 | 3.74 | 31.8 | 16.1 | ||||||||||||||||||||||
| 8 | 0.94 | 19.8 | 2.61 | ||||||||||||||||||||||
| Noguchi et al., 2013 [ | 49 | 5.5 | 110 | 20 | 0.003 | 0.2 | 0.02 | 2.5 | 2300 | 51 | |||||||||||||||
| 93 | 14 | 122 | 34 | ||||||||||||||||||||||
| 20 | 1.9 | 6.3 | 3.3 | 0.0008 | 0.006 | 0.03 | 0.8 | 5.5 | 1.9 | ||||||||||||||||
| 71 | 1 | 11 | 3.3 | ||||||||||||||||||||||
| Tokumaru et al., 2017 [ | 56 | 3.38 | 408 | 66 | 79.8 | ||||||||||||||||||||
| 10 | 1.35 | 3.48 | 2.24 | 0.71 | |||||||||||||||||||||
| Zheng et al., 2011 [ | 40 | 40.1 | |||||||||||||||||||||||
| 46 | 15 | ||||||||||||||||||||||||
| 39 | 2.94 | ||||||||||||||||||||||||
| Amankwaa et al., 2017 [ | 81 | 0.5 | 18.8 | 3.49 | 3.54 | ||||||||||||||||||||
| 33 | 0.3 | 8.2 | 3.54 | 2.5 | |||||||||||||||||||||
| 14 | 0 | 0 | 0 | 0 | |||||||||||||||||||||
| Asante et al., 2012 [ | 20 | 0.86 | 18.3 | 7.3 | 6.06 | 4.24 | |||||||||||||||||||
| 25 | 0.31 | 33.7 | 3.84 | 2.34 | 6.4 | ||||||||||||||||||||
| 3 | 2.98 | 7.27 | 4.61 | 4.27 | 2.32 | ||||||||||||||||||||
| Serum (μg/dL) | N/A | ||||||||||||||||||||||||
| Ceballos et al., 2017 [ | 46 | ND | 14 | ||||||||||||||||||||||
| Dartey et al., 2017 [ | 64 | 4.5 | 109.9 | 20 | <DL | 46 | 1.8 | 0.01 | 2.8 | 0.12 | |||||||||||||||
| 64 | 3.6 | 43.7 | 9.7 | <DL | 24 | 1.1 | 0.01 | 0.94 | 0.05 | ||||||||||||||||
| 65 | 3.4 | 47.8 | 10.2 | <DL | 6.1 | 0.6 | 0.01 | 0.42 | 0.04 | ||||||||||||||||
| 26 | 1.8 | 37.9 | 5.4 | <DL | 2.3 | 0.6 | 0.01 | 0.34 | 0.03 | ||||||||||||||||
| Julander et al., 2014 [ | 53 | 0.95 | 23 | 3.2 | 0.19 | 17 | 1.8 | ||||||||||||||||||
| 10 | 0.48 | 2.4 | 1.5 | 0.01 | 1.6 | 0.66 | |||||||||||||||||||
| 25 | 0.71 | 24 | 3.3 | 0.03 | 17 | 2.4 | |||||||||||||||||||
| 7 | 0.49 | 2.7 | 1.6 | 0.24 | 1.9 | 0.9 | |||||||||||||||||||
| Schecter et al., 2017 [ | 40 | 4.82 | 3.22 | ||||||||||||||||||||||
| 20 | 2.93 | 2.31 | |||||||||||||||||||||||
| Srigboh et al., 2016 [ | 58 | 7.93 | 5.8 | 6.35 | 4.01 | 9.98 | 14.22 | 9 | 8 | 7 | 4.9 | 9.7 | 14 | ||||||||||||
| 11 | 3.71 | 2.62 | 3.57 | 0.93 | 6 | 7.83 | 13.6 | 5.3 | 12.7 | 8.4 | 18.7 | 22 | |||||||||||||
| Wang et al., 2011 [ | 48 | 11.45 | 9.35 | 14.41 | 41 | 23 | 71 | ||||||||||||||||||
| 56 | 9.1 | 7.28 | 11.39 | 34 | 23 | 44 | |||||||||||||||||||
| Wittsiepe et al., 2017 [ | 72 | 3.1 | 35.1 | 10.19 | 8.85 | 17.9 | |||||||||||||||||||
| 40 | 2 | 10.3 | 4.43 | 4.1 | 5.65 | ||||||||||||||||||||
| Plasma (μg/dL) | <0.1 μg/dL 9 | ||||||||||||||||||||||||
| Li et al., 2014 [ | 30 | 9.04 | 4 | ||||||||||||||||||||||
| 28 | 6.84 | 1.61 | |||||||||||||||||||||||
1 Blood units converted to μg/dL from μg/L; 2 Urine reported in (μg/L) with no adjustment for creatinine or specific gravity; 3 Urine units converted to μg/g from ng/g. 4 Urine units converted to μg/g from μg/mg. 5 Urine sample concentration corrected using specific gravity. 6 Set by US Center for Disease Control and National Institute of Occupational Safety and Health [48]. 7 NHANES median value [49]. 8 95th %ile from the German Environmental Survey 1990–1992 [50,51]. 9 Non-exposed population in Sweden [50]. N/A indicates that no suitable reference or comparison value was found in the literature. Ref = Reference; Min = Minimum; Max = Maximum; SD = Standard Deviation; GM = Geometric Mean; Med = Median, 25th %ile = 25th percentile, 75th %ile = 75th percentile, 90th %ile = 90th percentile.
Results of data extraction from study set for Cd biomarkers in blood, urine, and hair.
| Authors |
| Reference Level | Reference Level | Reference Level | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Blood (μg/L) | 5 μg/L 5 | Urine (μg/g) | 5 μg/g 5 | Hair (μg/g) | 0.004–0.17 μg/g 6 | |||||||||||||||||||
| Min | Max | Mean | SD | GM | Med | 25th %ile | 75th %ile | 90th %ile | Min | Max | Mean | SD | GM | Med | 25th %ile | 75th %ile | 90th %ile | Min | Max | Mean | SD | GM | ||
| Asante et al., 2012 [ | 20 | 0.02 | 0.77 | 0.43 | 0.17 | 0.37 | ||||||||||||||||||
| 25 | 0.01 | 1.62 | 0.51 | 0.4 | 0.35 | |||||||||||||||||||
| 3 | 0.12 | 0.25 | 0.17 | 0.07 | 0.16 | |||||||||||||||||||
| Ceballos et al., 2017 [ | 46 | <LOD | 17 | <LOD | 1.1 | |||||||||||||||||||
| Dartey et al., 2017 [ | 64 | <LOD | 0.9 | 0.2 | LDR | LDR | LDR | |||||||||||||||||
| 64 | 0.1 | 0.7 | 0.3 | LDR | LDR | LDR | ||||||||||||||||||
| 65 | <LOD | 1.8 | 0.2 | LDR | LDR | LDR | ||||||||||||||||||
| 26 | <LOD | 4.2 | 0.3 | LDR | LDR | LDR | ||||||||||||||||||
| Ha et al., 2009 [ | 5 | 0.08 | 3.55 | 0.44 | ||||||||||||||||||||
| 6 | 0.03 | 0.1 | 0.05 | |||||||||||||||||||||
| 8 | 0.04 | 0.21 | 0.08 | |||||||||||||||||||||
| Julander et al., 2014 [ | 53 | 0.01 | 2.4 | 0.37 | ||||||||||||||||||||
| 10 | 0.18 | 0.61 | 0.27 | |||||||||||||||||||||
| 25 | 0.12 | 1.4 | 0.37 | |||||||||||||||||||||
| 7 | 0.17 | 0.3 | 0.27 | |||||||||||||||||||||
| Schecter et al., 2017 [ | 40 | 0.59 | 1 | |||||||||||||||||||||
| 20 | 0.59 | 0.83 | ||||||||||||||||||||||
| Srigboh et al., 2016 [ | 58 | 1.7 | 3 | 1.2 | 0.5 | 1.6 | 3.1 | |||||||||||||||||
| 11 | 1.4 | 0.5 | 1.3 | 1 | 1.7 | 2.5 | ||||||||||||||||||
| Tokumaru et al., 2017 [ | 56 | 0.01 | 2.16 | 0.32 | 0.43 | |||||||||||||||||||
| 10 | 0.02 | 0.14 | 0.06 | 0.04 | ||||||||||||||||||||
| Wang et al., 2011 [ | 48 | 1.29 | 0.76 | 4.06 | 1 | 1 | 2 | |||||||||||||||||
| 56 | 1.84 | 0.77 | 4.71 | 2 | 1 | 4 | ||||||||||||||||||
| Wittsiepe et al., 2017 [ | 72 | 0.2 | 2.1 | 0.55 | 0.51 | 0.87 | 0.01 | 1 | 0.18 | 0.12 | 0.36 | |||||||||||||
| 40 | 0.2 | 1.1 | 0.57 | 0.57 | 0.82 | 0.01 | 0.22 | 0.11 | 0.1 | 0.2 | ||||||||||||||
| Zhang et al., 2018 [ | 123 | 0.05 | 16.47 | 1.38 | 0.74 | 0.92 | 0.55 | 1.66 | ||||||||||||||||
| 113 | 0.1 | 14.39 | 1.59 | 0.92 | 1 | 0.69 | 1.77 | |||||||||||||||||
| 111 | 0.06 | 2.77 | 0.75 | 0.05 | 0.67 | 0.31 | 1.05 | |||||||||||||||||
| 101 | 0.04 | 3.2 | 0.76 | 0.06 | 0.59 | 0.29 | 0.9 | |||||||||||||||||
| Zheng et al., 2011 [ | 40 | 1.15 | ||||||||||||||||||||||
| 46 | 0.34 | |||||||||||||||||||||||
| 39 | 0.05 | |||||||||||||||||||||||
1 Blood units converted to μg/L from μg/dL. 2 Urine reported in μg/L with no adjustment for creatinine or specific gravity. 3 Urine sample concentration corrected using specific gravity. 4 Urine units converted to μg/g from μg/mg. 5 BEI level set by NIOSH [50]. 6 Proposed reference range from healthy Canadian population. N/A indicates that no suitable reference or comparison value was found in the literature. Min = Minimum; Max = Maximum; SD = Standard Deviation; GM = Geometric Mean; Med = Median, 25th %ile = 25th percentile, 75th %ile = 75th percentile, 90th %ile = 90th percentile.
Results of data extraction from study set for Sb, As, and Hg biomarkers in blood, serum, plasma, urine, and hair.
| Element |
| Antimony | Arsenic | Mercury | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biomarker | Blood (μg/L) | Urine (μg/g) | Hair (μg/g) | Blood (μg/L) | Serum (μg/L) | Urine (μg/g) | Hair (μg/g) | Blood (μg/L) | Serum (μg/L) | Urine (μg/g) | Hair (μg/g) | |||||||||
| Ref Values | 0.4 3 | 0.6 μg/L 3 | 0.003–0.13 4 | 2.6–17.8 4 | N/A | 35 μg/L 5 | 0.05 6 | 0.5 7 | N/A | 200 μg/L 5 | 2.2 8 | |||||||||
| Authors | Med | Mean | GM | Med | Mean | GM | GM | Mean | GM | Med | Mean | GM | Med | GM | GM | Med | Mean | GM | ||
| Asante et al., 2012 [ | 20 | 1.1 | 0.89 | 54.4 | 43.4 | <LOD | ||||||||||||||
| 25 | 0.32 | 0.24 | 85.8 | 76.4 | <LOD | |||||||||||||||
| 3 | 0.2 | 0.19 | 201 | 147 | <LOD | |||||||||||||||
| Dartey et al., 2017 [ | 64 | 0.75 | 3.5 | 2.1 | 75 | 3.6 | 0.7 | 0.22 | ||||||||||||
| 64 | 0.16 | 3.6 | 1.9 | 101 | 3.6 | 0.7 | 0.27 | |||||||||||||
| 65 | 0.18 | 3.8 | 2.2 | 82 | 4.3 | 0.8 | 0.26 | |||||||||||||
| 26 | 0.16 | 2.5 | 1.9 | 85 | 3.6 | 0.8 | 0.42 | |||||||||||||
| Ha et al., 2009 [ | 5 | 0.16 | 0.4 | |||||||||||||||||
| 6 | 0.23 | 0.1 | ||||||||||||||||||
| 8 | 0.02 | 0.19 | ||||||||||||||||||
| Huang et al., 2014 [ | 138 | 439.53 | ||||||||||||||||||
| 67 | 389.66 | |||||||||||||||||||
| 80 | 87.96 | |||||||||||||||||||
| Julander et al., 2014 [ | 53 | 2.2 | 0.18 | 13 | 1.4 | 1.4 | ||||||||||||||
| 10 | 2.2 | 0.12 | 19 | 1.2 | 0.66 | |||||||||||||||
| 25 | 2.3 | 0.26 | 18 | 1.3 | 1.1 | |||||||||||||||
| 7 | 2.3 | 0.09 | 21 | 1.5 | 0.99 | |||||||||||||||
| Ni et al., 2014 [ | 205 | 1.12 | ||||||||||||||||||
| 80 | 0.65 | |||||||||||||||||||
| Schecter et al., 2017 [ | 40 | 42.35 | 2.49 | 0.52 | ||||||||||||||||
| 20 | 46.94 | 3.46 | 0.34 | |||||||||||||||||
| Srigboh et al., 2016 [ | 58 | 77.5 | 38.3 | 0.9 | 0.2 | |||||||||||||||
| 11 | 117.5 | 92.5 | 1.1 | 0.3 | ||||||||||||||||
| Tang et al., 2015 [ | NR | 1.19 | ||||||||||||||||||
| NR | 0.88 | |||||||||||||||||||
| NR | 1.52 | |||||||||||||||||||
| NR | 1.4 | |||||||||||||||||||
| Tokumaru et al., 2017 [ | 56 | 0.77 | 0.11 | |||||||||||||||||
| 10 | 0.06 | 0.06 | ||||||||||||||||||
| Wittsiepe et al., 2017 [ | 72 | 0.18 | 0.46 | |||||||||||||||||
| 40 | 0.18 | 0.85 | ||||||||||||||||||
1 Urine reported in μg/L with no adjustment for creatinine or specific gravity. 2 Urine sample concentration corrected using specific gravity. 3 Occupationally-exposed glass workers (lowest exposure group selected) from glass industry [52]. 4 Proposed reference range [53]. 5 BEI set by ACGIH [54]. 6 US study control group median value [55]. 7 Median value for adults NHANES [56]. 8 FAO/WHO JECFA [57]. N/A indicates that no suitable reference or comparison value was found in the literature. Med = Median; GM = Geometric Mean.Arsenic was measured in blood, serum, urine, and hair. None of the six studies that examined As found a significant difference in biomarker As concentrations by exposure groups, and four of the six studies concluded that As exposures were due to environmental and dietary exposures [29,31,38,39]. Two studies examined various As species, including monomethylarsonic acid (MMA), dimethylarsinic acid (DMA), and arseobetaine (AB) [29,38].
Results of data extraction from study set for Cu, Fe, Ni, Zn biomarkers in blood, serum, plasma, urine, and hair.
| Element |
| Cu | Fe | Ni | Zn | ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biomarker | Blood (μg/L) | Serum (μg/L) | Plasma(μg/L) | Urine (μg/g) | Hair (μg/g) | Blood (μg/L) | Serum (μg/L) | Plasma (mM) | Urine (μg/g) | Hair (μg/g) | Blood (μg/L) | Serum (μg/L) | Urine (μg/g) | Hair (μg/g) | Blood (μg/L) | Serum (μg/L) | Plasma (μg/L) | Urine (μg/g) | Hair (μg/g) | ||||||||||||
| Ref Values | 1000 5 | 100–150 4 | 794–2023 6 | 4.3–12.1 6 | 8.51–34.97 6 | N/A | N/A | 0.04–5.31 6 | 58.73 7 | 16.9–29.6 6 | 0.09–4.18 6 | N/A | 0.59–4.06 6 | 0.51–1.53 8 | 7900 4 | N/A | 551–925 7 | 44–499 7 | 129–209 5 | ||||||||||||
| Authors | Med | GM | Med | GM | Mean | Med | GM | Med | Mean | GM | Med | GM | Mean | GM | Mean | Mean | Med | GM | GM | Med | Mean | GM | GM | GM | Mean | Med | GM | Med | Mean | GM | |
| Asante et al., 2012 [ | 20 | 254 | 130 | 614 | |||||||||||||||||||||||||||
| 25 | 77 | 44 | 713 | ||||||||||||||||||||||||||||
| 3 | 278 | 57 | 675 | ||||||||||||||||||||||||||||
| Dartey et al., 2017 [ | 64 | 1 | 1.1 | 13 | 6 | <LOD | <LOD | 3.1 | 7.1 | 0.9 | 178 | ||||||||||||||||||||
| 64 | 1.4 | 1.1 | 13 | 6.6 | <LOD | 0.9 | 2.9 | 7.1 | 0.8 | 234 | |||||||||||||||||||||
| 65 | 1.5 | 1 | 14 | 5.3 | <LOD | <LOD | 2.9 | 7.3 | 0.8 | 232 | |||||||||||||||||||||
| 26 | 1.6 | 1.5 | 14 | 11 | <LOD | <LOD | 3.6 | 6.6 | 0.8 | 243 | |||||||||||||||||||||
| Ha et al., 2009 [ | 5 | 23 | 141 | ||||||||||||||||||||||||||||
| 6 | 22.8 | 141 | |||||||||||||||||||||||||||||
| 8 | 7.77 | 116 | |||||||||||||||||||||||||||||
| Julander et al., 2014 [ | 53 | 760 | 870 | 460,000 | 0.99 | 1.8 | 710 | 470 | |||||||||||||||||||||||
| 10 | 800 | 880 | 470,000 | 0.25 | 1.5 | 810 | 410 | ||||||||||||||||||||||||
| 25 | 740 | 930 | 460,000 | 0.93 | 1.7 | 710 | 510 | ||||||||||||||||||||||||
| 7 | 760 | 970 | 450,000 | 1.2 | 1.5 | 840 | 520 | ||||||||||||||||||||||||
| Li et al., 2014 [ | 30 | 17.34 | μM | 8.43 | 100.66 | μM | |||||||||||||||||||||||||
| 28 | 15.2 | μM | 8.5 | 127.42 | μM | ||||||||||||||||||||||||||
| Srigboh et al., 2016 [ | 58 | 841 | 22.1 | 409,666 | 12.1 | 4645 | 511 | ||||||||||||||||||||||||
| 11 | 1071 | 65.3 | 391,849 | 26.6 | 4259 | 1116 | |||||||||||||||||||||||||
| Tokumaru et al., 2017 [ | 56 | 75 | 95.5 | 1.06 | 171 | ||||||||||||||||||||||||||
| 10 | 12.3 | 43.5 | 0.40 | 134 | |||||||||||||||||||||||||||
| Wang et al., 2010 [ | 100 | 1.26 | 800 | ||||||||||||||||||||||||||||
| 54 | 0.7 | 870 | |||||||||||||||||||||||||||||
| 59 | 1.82 | 700 | |||||||||||||||||||||||||||||
| 98 | 1.92 | 1280 | |||||||||||||||||||||||||||||
| 34 | 0 | 910 | |||||||||||||||||||||||||||||
| 32 | 1.71 | 680 | |||||||||||||||||||||||||||||
| Wang et al., 2011 [ | 48 | 26 | |||||||||||||||||||||||||||||
| 56 | 25 | ||||||||||||||||||||||||||||||
| Wittsiepe et al., 2017 [ | 72 | 3.18 | |||||||||||||||||||||||||||||
| 40 | 2.03 | ||||||||||||||||||||||||||||||
| Zheng et al., 2011 [ | 40 | 29.81 | 0.74 | 138.95 | |||||||||||||||||||||||||||
| 46 | 17.67 | 0.59 | 112.51 | ||||||||||||||||||||||||||||
| 39 | 9.85 | 0.81 | 122.99 | ||||||||||||||||||||||||||||
1 Urine reported in μg/L with no adjustment for creatinine or specific gravity. 2 Urine sample concentration corrected using specific gravity. 3 Urine values converted from μg/mg to μg/g. 4 Healthy adult reference range [58]. 5 95th percentile reference value from a healthy male Canadian population [59]. 6 Proposed reference range [53]. 7 Mean value from 24-h urine sample of healthy adults [60]. 8 Reference range reported from a Polish population [61]. N/A indicates that no suitable reference or comparison value was found in the literature. Med = Median; GM = Geometric Mean.